F10 and systemic lupus erythematosus: In our (larger) cohort, we found anti-FXa IgG to be significantly elevated in 20 of 59 patients (34.5%) with APS and a higher proportion (52 of 109, 49.1%) of patients with SLE who did not have APS compared with ARD and healthy controls.